PharmaBlock Sciences (Nanjing), Inc. (SZSE:300725) is a leading provider of innovative chemistry products & services throughout the pharmaceutical R&D process and commercial production. Its core businesses include: a rationally designed building blocks (BBs) collection, supplying from discovery, to development & commercial; development & manufacturing of RSMs, intermediates & APIs for drug development & commercial.
Officially operated in 2008, PharmaBlock has rapidly gained recognition for its outstanding capabilities in the design, synthesis, & supply of novel BBs. It has generated a large and unique collection of high-quality and diverse BBs, which are increasingly adopted by drug hunters to enrich the structure options, improve compound quality, expand patent space and eventually accelerate drug discovery projects. Inspired by the BBs, it has established a powerful drug discovery platform for medicinal chemists to quickly identify hit/lead. The platform includes a set of efficient tools, including but not limited to FBDD, DELT, & Virtual Screening.
Following the new molecules advancing from discovery to development, and into the market, the company is committed to a more comprehensive & long-term service to valued customers. In addition to strengthening process R&D capabilities & mfg. capacity to secure the sustainable supply of BBs, the company is providing CDMO solutions of RSMs, key intermediates & APIs. To further realize safe, efficient and green process & mfg., it has developed an advanced chemistry & engineering technology platform, featuring flow chemistry, micropacked bed hydrogenation, catalysis, crystallization, solid state chemistry etc.
Over the past years, PharmaBlock has partnered with almost all the top pharmaceutical companies, and hundreds of small to medium-sized biotechs around the world. Our ever changing mission is to support clients to accelerate drug discovery & development, and move the new molecule to commercial in full speed.
Company Details
- Employees
- 236
- Founded
- -
- Address
- 81 Huasheng Road, Jiangbei New Area, Nanjing,jiangsu 210032,china
- Phone
- 86-400 025 5188
- PB****@****ock.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.pharmablock.com
- Keywords
- Building blocks, Custom synthesis, Manufacturing of key intermediates and APIs, FTE services, Process R&D, CMC, GMP, CDMO, flow chemistry, catalysis, micropacked bed, fbdd, DEL, Virtual screening.
- HQ
- Nanjing, Jiangsu
Pharmablock Group Questions
Pharmablock Group's helpline number is 86-400 025 5188
Pharmablock Group's website is http://www.pharmablock.com
Pharmablock Group's LinkedIn profile is https://www.linkedin.com/company/pharmablock
Pharmablock Group has
236 employees.
View email and phone details for 236
employees at Pharmablock Group.
Pharmablock Group's industry is
Pharmaceutical Manufacturing
Pharmablock Group's top competitors are
Biocartesian,
Aoic, Llc,
Kingchem,
Pharmablock (Usa), Inc.,
Incyte,
Pharmaron,
Phlow,
Asymchem Group,
Enamine Ltd.,
Givax, Inc..
Pharmablock Group's support email address is PB-Stock@PharmaBlock.com
Pharmablock Group's categories are Pharmaceutical Manufacturing
Pharmablock Group's founding year is 2006
